New Directions in Triple-Negative Breast Cancer Diagnostics
A novel PD-L1 assay advances the promise of precision medicine.
Read More
Search Results for: lung cancer
Key Trends in AI and Digital Pathology
Artificial intelligence promises gains in efficiency and accuracy for clinical laboratories.
Read More
Susan G. Komen Unveils Nearly $26 Million Investment in Research with a Focus on Metastatic Breast Cancer
The 2019 grants focus on key areas that will help the organization halve the current number of breast cancer deaths in the United States by 2026.
Read More
Trial Demonstrates Potential of Blood Test to Reduce Late Detection of Lung Cancer
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read More
Roche Launches Companion Diagnostic to Identify Triple-Negative Breast Cancer Patients Eligible for Treatment with Tecentriq
The Ventana PD-L1 assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy.
Read More